Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
156.87
-0.95 (-0.60%)
At close: Jan 30, 2026, 4:00 PM EST
157.00
+0.13 (0.08%)
After-hours: Jan 30, 2026, 7:59 PM EST

Insmed Revenue

Insmed had revenue of $142.34M in the quarter ending September 30, 2025, with 52.36% growth. This brings the company's revenue in the last twelve months to $447.02M, up 30.34% year-over-year. In the year 2024, Insmed had annual revenue of $363.71M with 19.17% growth.

Revenue (ttm)
$447.02M
Revenue Growth
+30.34%
P/S Ratio
66.80
Revenue / Employee
$351,709
Employees
1,271
Market Cap
33.46B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024363.71M58.50M19.17%
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 201311.50M--
Dec 31, 2012---
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG4.97B
Incyte4.81B
Genmab3.85B
BioNTech SE3.70B
argenx SE3.68B
Alnylam Pharmaceuticals3.21B
Royalty Pharma2.35B
Moderna2.23B
Revenue Rankings